choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Truvada

Truvada Newsletter
  • 20 Biggest Publicly Traded Biotech Companies 26 May 2024 03:14 GMT

    … It also introduced Truvada, the first medication approved for pre … treatment in 1987 and the first single-pill, two-drug … and 36 clinical trials before the first … global pharmaceutical and biotechnology company. The company introduced innovative medicines

  • New Book To Watch Out: Specialty Drugs For Pharmacy Patients 21 May 2024 13:23 GMT

    … HIV prevention, focusing on medications such as Truvada and Descovy. It covers … treatment drugs like Lonsurf and Jakafi. It emphasizes preventing medication errors and adverse drug … with profound expertise in the pharmaceutical industry. Based in Kentucky, …

  • Specialty Drugs for Patients in Pharmacy Press 21 May 2024 07:45 GMT

    … HIV prevention, focusing on medications such as Truvada and Descovy. It covers … treatment drugs like Lonsurf and Jakafi. It emphasizes preventing medication errors and adverse drug … with profound expertise in the pharmaceutical industry. Based in Kentucky, …

  • HIV Drugs Market Size Is Set to Grow by USD 10.47 Billion From 2023-2027 23 Apr 2024 16:49 GMT

    … Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Torrent Pharmaceuticals Ltd., … treatment with HIV medications. Key Market Drivers The HIV drugs … Dovato, Emtriva, Epivir, Epzicom, Truvada, Biktavir, Edurant, Aptivus, Kaletra, …

  • HIV crisis in Atlanta made worse by racial disparities in treatment 16 Apr 2024 10:08 GMT

    … orally or intravenously, the drugs reduce the risk of contracting … the generic form of Truvada, an oral form of … in overall HIV treatment and prevention. PrEP pills and quarterly blood … adherence to HIV medications, otherwise known as “pill fatigue.” Many …

  • B.C. class action suit approved against HIV/AIDs drugmaker Gilead 26 Mar 2024 06:03 GMT

    … against a pharmaceutical company that develops drugs to treat … TDF drugs in Canada under the brands Viread, Truvada, Atripla … and their families. The trial will try to determine … , wellness, healthy living, drugs, treatments and more, head to Healthing …

  • ‘Temporary’ Shortage Of Lifesaving HIV Drugs Hits MOH 12 Mar 2024 02:29 GMT

    drug, produced by India’s Hetero Healthcare Ltd, of the branded Truvada … standard ART treatment, consists of a combination of drugs that suppress replication … further conducts thorough monitoring of medicines involved in supply disruptions to …

  • Germany Into Third Month Struggling to Access Lifesaving HIV Drug 11 Mar 2024 06:59 GMT

    medication. Landmann resorted to taking the pills less regularly. This drug … Gilead Sciences Inc.’s Truvada, would cost insurers … treatment plans,” said Berlin-based infectious disease doctor … current situation,” Teva Pharmaceutical Industries Ltd.’s …

  • Human medicines European public assessment report (EPAR): Truvada, emtricitabine,tenofovir disoproxil, Date of authorisation: 20/02/2005, Revision: 47, Status: Authorised 29 Feb 2024 17:57 GMT

    … . Truvada’s active substances, taken in combination with other antiviral medicines, … lamivudine and zidovudine (other antiviral medicines). Both combinations were taken with … both studies Truvada was compared with placebo (a dummy treatment) in adults …

  • Biktarvy Indication Expanded by FDA for Resistant HIV 27 Feb 2024 18:38 GMT

    … ;I mutation. The FDA has approved an expanded … 47;tenofovir alafenamide) or Truvada (emtricitabine/tenofovir disoproxil … trial participants after three years of follow-up, with 97% of treatment … of treatment-emergent resistance. The most common drug-related …

Satisfied with the content?

Continue to create your account.